The United States District Court for the District of New Jersey has ruled that AstraZeneca's US patent protecting Pulmicort Respules in the US, is invalid. The Court also said that the generic defendants involved in the litigation do not ...
Tags: Pulmicort, Health, Pulmicort Patent
Watson Laboratories,a subsidiary of Watson Pharmaceuticals,has won FDA approval for its abbreviated new drug application(ANDA)for Budesonide inhalation suspension 0.25mg/2mL and 0.5mg/2mL unit-dose ampoules. Budesonide Inhalation ...